155 related articles for article (PubMed ID: 30692024)
1. Amino acid based prodrugs of a fosmidomycin surrogate as antimalarial and antitubercular agents.
Courtens C; Risseeuw M; Caljon G; Maes L; Martin A; Van Calenbergh S
Bioorg Med Chem; 2019 Mar; 27(5):729-747. PubMed ID: 30692024
[TBL] [Abstract][Full Text] [Related]
2. Phosphonodiamidate prodrugs of N-alkoxy analogs of a fosmidomycin surrogate as antimalarial and antitubercular agents.
Courtens C; Risseeuw M; Caljon G; Cos P; Martin A; Van Calenbergh S
Bioorg Med Chem Lett; 2019 May; 29(9):1051-1053. PubMed ID: 30857749
[TBL] [Abstract][Full Text] [Related]
3. Prodrugs of reverse fosmidomycin analogues.
Brücher K; Gräwert T; Konzuch S; Held J; Lienau C; Behrendt C; Illarionov B; Maes L; Bacher A; Wittlin S; Mordmüller B; Fischer M; Kurz T
J Med Chem; 2015 Feb; 58(4):2025-35. PubMed ID: 25633870
[TBL] [Abstract][Full Text] [Related]
4. Acyloxymethyl and alkoxycarbonyloxymethyl prodrugs of a fosmidomycin surrogate as antimalarial and antibacterial agents.
Courtens C; van Charante F; Quennesson T; Risseeuw M; Cos P; Caljon G; Coenye T; Van Calenbergh S
Eur J Med Chem; 2023 Jan; 245(Pt 1):114924. PubMed ID: 36399924
[TBL] [Abstract][Full Text] [Related]
5. Double prodrugs of a fosmidomycin surrogate as antimalarial and antitubercular agents.
Courtens C; Risseeuw M; Caljon G; Maes L; Cos P; Martin A; Van Calenbergh S
Bioorg Med Chem Lett; 2019 May; 29(10):1232-1235. PubMed ID: 30879839
[TBL] [Abstract][Full Text] [Related]
6. Double ester prodrugs of FR900098 display enhanced in-vitro antimalarial activity.
Wiesner J; Ortmann R; Jomaa H; Schlitzer M
Arch Pharm (Weinheim); 2007 Dec; 340(12):667-9. PubMed ID: 17994601
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antimalarial evaluation of prodrugs of novel fosmidomycin analogues.
Faísca Phillips AM; Nogueira F; Murtinheira F; Barros MT
Bioorg Med Chem Lett; 2015; 25(10):2112-6. PubMed ID: 25881827
[TBL] [Abstract][Full Text] [Related]
8. Acyloxyalkyl ester prodrugs of FR900098 with improved in vivo anti-malarial activity.
Ortmann R; Wiesner J; Reichenberg A; Henschker D; Beck E; Jomaa H; Schlitzer M
Bioorg Med Chem Lett; 2003 Jul; 13(13):2163-6. PubMed ID: 12798327
[TBL] [Abstract][Full Text] [Related]
9. Novel reverse thia-analogs of fosmidomycin: Synthesis and antiplasmodial activity.
Lienau C; Gräwert T; Alves Avelar LA; Illarionov B; Held J; Knaab TC; Lungerich B; van Geelen L; Meier D; Geissler S; Cynis H; Riederer U; Buchholz M; Kalscheuer R; Bacher A; Mordmüller B; Fischer M; Kurz T
Eur J Med Chem; 2019 Nov; 181():111555. PubMed ID: 31382119
[TBL] [Abstract][Full Text] [Related]
10. Resistance to the antimicrobial agent fosmidomycin and an FR900098 prodrug through mutations in the deoxyxylulose phosphate reductoisomerase gene (dxr).
Armstrong CM; Meyers DJ; Imlay LS; Freel Meyers C; Odom AR
Antimicrob Agents Chemother; 2015 Sep; 59(9):5511-9. PubMed ID: 26124156
[TBL] [Abstract][Full Text] [Related]
11. Alkoxycarbonyloxyethyl ester prodrugs of FR900098 with improved in vivo antimalarial activity.
Ortmann R; Wiesner J; Reichenberg A; Henschker D; Beck E; Jomaa H; Schlitzer M
Arch Pharm (Weinheim); 2005 Jul; 338(7):305-14. PubMed ID: 15996004
[TBL] [Abstract][Full Text] [Related]
12. Conformationally restrained aromatic analogues of fosmidomycin and FR900098.
Kurz T; Schlüter K; Pein M; Behrendt C; Bergmann B; Walter RD
Arch Pharm (Weinheim); 2007 Jul; 340(7):339-44. PubMed ID: 17611943
[TBL] [Abstract][Full Text] [Related]
13. Reverse fosmidomycin derivatives against the antimalarial drug target IspC (Dxr).
Behrendt CT; Kunfermann A; Illarionova V; Matheeussen A; Pein MK; Gräwert T; Kaiser J; Bacher A; Eisenreich W; Illarionov B; Fischer M; Maes L; Groll M; Kurz T
J Med Chem; 2011 Oct; 54(19):6796-802. PubMed ID: 21866890
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and X-ray crystallographic studies of α-aryl substituted fosmidomycin analogues as inhibitors of Mycobacterium tuberculosis 1-deoxy-D-xylulose 5-phosphate reductoisomerase.
Andaloussi M; Henriksson LM; Więckowska A; Lindh M; Björkelid C; Larsson AM; Suresh S; Iyer H; Srinivasa BR; Bergfors T; Unge T; Mowbray SL; Larhed M; Jones TA; Karlén A
J Med Chem; 2011 Jul; 54(14):4964-76. PubMed ID: 21678907
[TBL] [Abstract][Full Text] [Related]
15. A second target of the antimalarial and antibacterial agent fosmidomycin revealed by cellular metabolic profiling.
Zhang B; Watts KM; Hodge D; Kemp LM; Hunstad DA; Hicks LM; Odom AR
Biochemistry; 2011 May; 50(17):3570-7. PubMed ID: 21438569
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of alpha-substituted fosmidomycin analogues as highly potent Plasmodium falciparum growth inhibitors.
Haemers T; Wiesner J; Van Poecke S; Goeman J; Henschker D; Beck E; Jomaa H; Van Calenbergh S
Bioorg Med Chem Lett; 2006 Apr; 16(7):1888-91. PubMed ID: 16439126
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo synergy of fosmidomycin, a novel antimalarial drug, with clindamycin.
Wiesner J; Henschker D; Hutchinson DB; Beck E; Jomaa H
Antimicrob Agents Chemother; 2002 Sep; 46(9):2889-94. PubMed ID: 12183243
[TBL] [Abstract][Full Text] [Related]
18. DXR inhibition by potent mono- and disubstituted fosmidomycin analogues.
Jansson AM; Więckowska A; Björkelid C; Yahiaoui S; Sooriyaarachchi S; Lindh M; Bergfors T; Dharavath S; Desroses M; Suresh S; Andaloussi M; Nikhil R; Sreevalli S; Srinivasa BR; Larhed M; Jones TA; Karlén A; Mowbray SL
J Med Chem; 2013 Aug; 56(15):6190-9. PubMed ID: 23819803
[TBL] [Abstract][Full Text] [Related]
19. MEPicides: α,β-Unsaturated Fosmidomycin Analogues as DXR Inhibitors against Malaria.
Wang X; Edwards RL; Ball H; Johnson C; Haymond A; Girma M; Manikkam M; Brothers RC; McKay KT; Arnett SD; Osbourn DM; Alvarez S; Boshoff HI; Meyers MJ; Couch RD; Odom John AR; Dowd CS
J Med Chem; 2018 Oct; 61(19):8847-8858. PubMed ID: 30192536
[TBL] [Abstract][Full Text] [Related]
20. Reverse
Abdullaziz MA; Takada S; Illarionov B; Pessanha de Carvalho L; Sakamoto Y; Höfmann S; Knak T; Kiffe-Delf AL; Mazzone F; Pfeffer K; Kalscheuer R; Bacher A; Held J; Fischer M; Tanaka N; Kurz T
ACS Infect Dis; 2024 May; 10(5):1739-1752. PubMed ID: 38647213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
